[Anti-anginal effect of long-term use of obsidan, corinfar and finoptin in patients with stable exercise-induced stenocardia].
作者信息
Furkalo N K, Voronkov L G, Sokolov N F, Lysenko A F
出版信息
Klin Med (Mosk). 1991 Jan;69(1):63-6.
PMID:2023398
Abstract
Time course changes in antianginal effect were evaluated for obsidan, corinfar and finoptin under 12-week administration in 104 patients with stable angina pectoris. The response to finoptin appeared to rise while for obsidan and corinfar it was stable. Some patients with stable angina developed clinical tolerance to corinfar.
摘要
相似文献
1
[Anti-anginal effect of long-term use of obsidan, corinfar and finoptin in patients with stable exercise-induced stenocardia].
Klin Med (Mosk). 1991 Jan;69(1):63-6.
2
[The efficacy of the long-term therapy of patients with stable stenocardia using korinfar and finoptin].
Vrach Delo. 1989 Jul(7):67-9.
3
4
[Changes in the physical load tolerance of stenocardia patients taking obzidan, korinfar and izoptin separately and together].
Kardiologiia. 1984 Jun;24(6):69-73.
5
[Comparative effectiveness of finoptin, corinfar and their combination in patients with angina pectoris].
Kardiologiia. 1984 Nov;24(11):91-6.
6
[Effect of a single dose of anaprilin and corinfar on the results of the bicycle ergometric test in patients with stenocardia].
Kardiologiia. 1985 Jul;25(7):85-9.
7
[Comparative effectiveness and biological equivalency of new nifedipine preparations in patients with exercise-induced stenocardia].
Klin Med (Mosk). 1990 Sep;68(9):50-2.
8
[Synergism of the anti-anginal action of beta-blockers and calcium antagonists in patients with ischemic heart disease].
Kardiologiia. 1985 Sep;25(9):45-8.
9
[Drug therapy combinations in angina pectoris].
Arch Mal Coeur Vaiss. 1983 Feb;76 Spec No:103-9.
10
[Clinical aspects of trimetazidine (preductal) administration as an antianginal drug].
Ter Arkh. 2000;72(8):20-3.
Zotero 插件